Cargando…
FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD‐L1 Expression and Cell Proliferation (Adv. Sci. 29/2022)
Immunotherapy The FOXM1 inhibitor, thiostrepton, inhibits the expression of programmed death‐ligand 1 (PD‐L1) on the surface of cancer cells, allowing cytotoxic T cells to recognize cancer cells. Combination of thiostrepton and an immune checkpoint inhibitor significantly improves immunotherapy outc...
Autores principales: | Madhi, Hamadi, Lee, Jeon‐Soo, Choi, Young Eun, Li, Yan, Kim, Myoung Hee, Choi, Yongdoo, Goh, Sung‐Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561766/ http://dx.doi.org/10.1002/advs.202270183 |
Ejemplares similares
-
Front Cover: (Adv. Sci. 19/2022)
Publicado: (2022) -
Slippery, Water‐Infused Membrane with Grooved Nanotrichomes for Lubricating‐Induced Oil Repellency (Adv. Sci. 13/2022)
por: Lee, Young A, et al.
Publicado: (2022) -
High‐Resolution 3D Printing for Electronics (Adv. Sci. 8/2022)
por: Park, Young‐Geun, et al.
Publicado: (2022) -
Advances in Biomimetic Photoelectrocatalytic Reduction of Carbon Dioxide (Adv. Sci. 31/2022)
por: Xu, Shaohan, et al.
Publicado: (2022) -
Multi‐Modal Locomotion of Caenorhabditis elegans by Magnetic Reconfiguration of 3D Microtopography (Adv. Sci. 36/2022)
por: Park, Jeong Eun, et al.
Publicado: (2022)